Soluble TREM-1 Levels in Familial Mediterranean Fever Related AA-Amyloidosis

References

• Bassyouni IH, Fawzi S, Gheita TA, Bassyouni RH, Nasr AS, El Bakry SA, Afifi N. 2017. Clinical association of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) in patients with systemic lupus erythematosus. Immunol Invest. 46(1):38–47.
   PubMed Web of Science ®Google Scholar
• Bishara J, Hadari N, Shalita-Chesner M, Samra Z, Ofir O, Paul M, Peled N, Pitlik S, Molad Y. 2007. Soluble triggering receptor expressed on myeloid cells-1 for distinguishing bacterial from aseptic meningitis in adults. Eur J Clin Microbiol Infect Dis. 26(9):647–50.
   PubMed Web of Science ®Google Scholar
• Bomfim LGS, Magalhães LS, Santos-Filho MAA, Peres NTA, Corrêa CB, Tanajura DM, Silva AM, Lipscomb MW, Borges VM, Jesus AR, et al. 2017 Nov 16. Leishmania infantum induces the release of sTREM-1 in visceral leishmaniasis. Front Microbiol. 8:2265. doi:10.3389/fmicb.2017.02265.
   PubMed Web of Science ®Google Scholar
• Bouchon A, Facchetti F, Weigand MA, Colonna M. 2001. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 410(6832):1103–07.
   PubMed Web of Science ®Google Scholar
• Determann RM, Weisfelt M, de Gans J, van der Ende A, Schultz MJ, van de Beek D. 2006. Soluble triggering receptor expressed on myeloid cells 1: a biomarker for bacterial meningitis. Intensive Care Med. 32(8):1243–47.
   PubMed Web of Science ®Google Scholar
• Essa ES, Elzorkany KM. 2015. sTREM-1 in patients with chronic kidney disease on hemodialysis. APMIS. 123(11):969–74.
   PubMed Web of Science ®Google Scholar
• Gao S, Yi Y, Xia G, Yu C, Ye C, Tu F, Shen L, Wang W, Hua C. 2019. The characteristics and pivotal roles of triggering receptor expressed on myeloid cells-1 in autoimmune diseases. Autoimmun Rev. 18(1):25–35.
   PubMed Web of Science ®Google Scholar
• Georgin-Lavialle S, Fayand A, Rodrigues F, Bachmeyer C, Savey L, Grateau G. 2019. Autoinflammatory diseases: state of the art. Presse Med. Feb;48(1):e25–e48.
   PubMed Web of Science ®Google Scholar
• Gibot S, Cravoisy A, Levy B, Bene M-C, Faure G, Bollaert P-E. 2004. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 350(5):451–58.
   PubMed Web of Science ®Google Scholar
• Gibot S, Le Renard P-E, Bollaert P-E, Kolopp-Sarda M-N, Béné M-C, Faure GC, Lévy B. 2005. Surface triggering receptor expressed on myeloid cells 1 expression patterns in septic shock. Intensive Care Medicine. 31(4):594–97.
   PubMed Web of Science ®Google Scholar
• Gómez-Piña V, Soares-Schanoski A, Rodríguez-Rojas A, Del Fresno C, García F, Vallejo-Cremades MT, Fernández-Ruiz I, Arnalich F, Fuentes-Prior P, López-Collazo E, et al. 2007. Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. J Immunol. 179(6):4065–73.
   PubMed Web of Science ®Google Scholar
• Gorlier C, Sellam J, Laurans L, Simon T, Giurgea I, Bastard J-P, Fellahi S, Deshayes S, Grateau G, Ait Oufella H, et al. 2019 Nov. In familial Mediterranean fever, soluble TREM-1 plasma level is higher in case of amyloidosis. Innate Immun. 25(8):487–90. doi:10.1177/1753425919870847.
   PubMed Web of Science ®Google Scholar
• Jung YS, Kim SW, Yoon JY, Lee JH, Jeon SM, Hong SP, Kim TI, Kim WH, Cheon JH. 2011. Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcetʼs disease. Inflamm Bowel Dis. 17(10):2130–37.
   PubMed Web of Science ®Google Scholar
• Kuai J, Gregory B, Hill A, Pittman DD, Feldman JL, Brown T, Carito B, O’Toole M, Ramsey R, Adolfsson O, et al. 2009. TREM-1 expression is increased in the synovium of rheumatoid arthritis patients and induces the expression of pro-inflammatory cytokines. Rheumatology (Oxford). 48(11):1352–58.
   PubMed Web of Science ®Google Scholar
• Lee J, Lee S-Y, Lee J, Lee J, Baek S, Lee D-G, Kim E-K, Lee SH, Cho M-L, Kwok S-K, et al. 2016. Monosodium urate crystal-induced triggering receptor expressed on myeloid cells 1 is associated with acute gouty inflammation. Rheumatology (Oxford). 55(1):156–61.
   PubMed Web of Science ®Google Scholar
• Livneh A, Zemer D, Langevitz P, Shemer J, Sohar E, Pras M. 1993 Dec. Colchicine in the treatment of AA and AL amyloidosis. Semin Arthritis Rheum. 23(3):206–14. Review doi:10.1016/S0049-0172(05)80042-3.
   PubMed Web of Science ®Google Scholar
• Molad Y, Pokroy-Shapira E, Kaptzan T, Monselise A, Shalita-Chesner M, Monselise Y. 2013. Serum soluble triggering receptor on myeloid cells-1 (sTREM-1) is elevated in systemic lupus erythematosus but does not distinguish between lupus alone and concurrent infection. Inflammation. 36(6):1519–24.
   PubMed Web of Science ®Google Scholar
• Nguyen-Lefebvre AT, Ajith A, Portik-Dobos V, Horuzsko DD, Arbab AS, Dzutsev A, Sadek R, Trinchieri G, Horuzsko A. 2018 Nov 1. The innate immune receptor TREM-1 promotes liver injury and fibrosis. J Clin Invest. 128(11):4870–83. Epub 2018 Oct 2. doi:10.1172/JCI98156.
   PubMed Web of Science ®Google Scholar
• Park JJ, Cheon JH, Kim BY, Kim DH, Kim ES, Kim TI, Lee KR, Kim WH. 2009. Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease. Dig Dis Sci. 54(7):1525–31.
   PubMed Web of Science ®Google Scholar
• Radsak MP, Salih HR, Rammensee H-G, Schild H. 2004. Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. J Immunol. 172(8):4956–63.
   PubMed Web of Science ®Google Scholar
• Roe K, Gibot S, Verma S. 2014. Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity? Front Microbiol. 26(5):627.
   Google Scholar
• Selvi O, Ugurlu S, Bolayirli M, Barut K, Sahin S, Adrovic A, Akker M, Ergezen B, Simsek O, Kasapcopur O, et al. 2017. C-reactive protein and serum amyloid a in sepsis, acute appendicitis and familial Mediterranean fever [abstract]. 320 Arthritis Rheumatol. 69(suppl):10.
   Google Scholar
• Sharif O, Knapp S. 2008. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology. 213(9–10):701–13.
   PubMed Web of Science ®Google Scholar
• Tammaro A, Derive M, Gibot S, Leemans JC, Florquin S, Dessing MC. 2017. TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives. Pharmacol Ther. 177:81–95.
   PubMed Web of Science ®Google Scholar
• Tomita H, Ogawa F, Hara T, Yanaba K, Iwata Y, Muroi E, Yoshizaki A, Komura K, Takenaka M, Shimizu K, et al. 2010. Elevated serum concentrations of triggering receptor expressed on myeloid cells-1 in diffuse cutaneous systemic sclerosis: association with severity of pulmonary fibrosis. J Rheumatol. 37(4):787–91.
   PubMed Web of Science ®Google Scholar